Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Quinoline compounds >  6-METHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLINE

6-METHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLINE

Basic information Safety Supplier Related

6-METHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLINE Basic information

Product Name:
6-METHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLINE
Synonyms:
  • 1,2,3,4-tetrahydro-6-methoxy-isoquinolin
  • ISOQUINOLINE, 1,2,3,4-TETRAHYDRO-6-METHOXY-
  • CHEMBRDG-BB 4101917
  • 6-METHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLINE
  • AKOS BC-2988
  • m90104
  • 6-methoxy-1,2,3,4-tetrahydroisoquinoline(SALTDATA: FREE)
  • 1,2,3,4-Tetrahydro-6-methoxyisoquinoline
CAS:
42923-77-3
MF:
C10H13NO
MW:
163.22
EINECS:
824-738-5
Mol File:
42923-77-3.mol
More
Less

6-METHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLINE Chemical Properties

Boiling point:
144°C/9mmHg(lit.)
Density 
1.044±0.06 g/cm3(Predicted)
refractive index 
1.5660 to 1.5700
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
solubility 
Chloroform (Slightly), Methanol (Slightly, Sonicated)
form 
Pale Yellow to Yellow Semi-Solid
pka
10.02±0.20(Predicted)
color 
Colorless to Light orange to Yellow
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22-51
RTECS 
NX5082000
HazardClass 
IRRITANT
HS Code 
2933499090
More
Less

6-METHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLINE Usage And Synthesis

Uses

6-Methoxy-1,2,3,4-tetrahydroisoquinoline is used in the synthesis of novel spirobicyclic Artemisinin (A777500) analogues for anti-tumor activity.

Synthesis

22246-12-4

42923-77-3

6.1.18 Synthesis of 6-methoxy-1,2,3,4-tetrahydroisoquinoline (35): to an anhydrous tetrahydrofuran (THF, 20 mL) solution of 6-(methoxy)-3,4-dihydro-1(2H)-isoquinolone (34, 1.4 g, 7.9 mmol) was added slowly under nitrogen protection lithium aluminum hydride (LiAlH4, 601 mg, 15.8 mmol). The reaction mixture was stirred at 60 °C overnight. Upon completion of the reaction, it was cooled to room temperature and the reaction was quenched by sequential addition of water (0.6 mL) and 15% sodium hydroxide (NaOH) solution (0.6 mL), and stirring was continued for 30 minutes. The reaction mixture was filtered and the filtrate was concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (eluent: dichloromethane/methanol=20:1) to afford the target product 35 (1.06 g, 77% yield) as a yellow oil.1H NMR (400 MHz, CDCl3): δ 6.94 (d, J=8.0 Hz, 1H), 6.71 (d, J=8.0 Hz, 1H), 6.63 (s 1H), 4.00 (s, 2H), 3.78 (s, 3H), 3.16 (t, J=5.6Hz, 2H), 2.83 (t, J=5.2Hz, 2H).

References

[1] Journal of Medicinal Chemistry, 1987, vol. 30, # 12, p. 2208 - 2216
[2] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1993, vol. 32, # 12, p. 1209 - 1213
[3] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 2, p. 207 - 219
[4] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 4, p. 789 - 801
[5] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 21, p. 6855 - 6868

6-METHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLINESupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Tetranov Biopharm
Tel
13526569071
Email
sales@leadmedpharm.com